Genomic expression profiling of NK cells in health and disease

European Journal of Immunology

Volumn 45, Issue 3, 2015, Pages 661-678

  Wang, Fuyan ^a,b   Tian, Zhigang ^a   Wei, Haiming ^a  

^a UNIVERSITY OF SCIENCE AND TECHNOLOGY OF CHINA   (China)

^b NINGBO UNIVERSITY   (China)

Author keywords

Gene expression; Genomic profiling; Microarray; Natural killer cell; Transcriptome

Indexed keywords

NATURAL KILLER CELL RECEPTOR;

ADOPTIVE IMMUNOTHERAPY; ADOPTIVE TRANSFER; ARTICLE; CANCER IMMUNOTHERAPY; CELLULAR DISTRIBUTION; DECIDUA; DEVELOPMENT; DISEASES; GENE EXPRESSION PROFILING; GENOMICS; HEALTH; HUMAN; IMMUNOCOMPETENT CELL; IMMUNOGENETICS; LIVER; LYMPHOCYTE; LYMPHOCYTE ACTIVATION; LYMPHOCYTE FUNCTION; LYMPHOCYTE SUBPOPULATION; NATURAL KILLER CELL; NATURAL KILLER CELL MEDIATED CYTOTOXICITY; NEOPLASM; NONHUMAN; PARASITOSIS; PRIORITY JOURNAL; T CELL DEPLETION; TUMOR MICROENVIRONMENT; VIRUS INFECTION; VIRUS INFECTIVITY; ANIMAL; GENE EXPRESSION REGULATION; GENETIC DATABASE; IMMUNOLOGY; METABOLISM; MOUSE; PHYSIOLOGY;

ANIMALS; DATABASES, GENETIC; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENOMICS; HUMANS; KILLER CELLS, NATURAL; MICE;

EID: 84924626927     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.201444998     Document Type: Article

References (92)

1. Vivier, E., Raulet, D. H., Moretta, A., Caligiuri, M. A., Zitvogel, L., Lanier, L. L., Yokoyama, W. M. et al., Innate or adaptive immunity? The example of natural killer cells. Science 2011. 331: 44-49.
2. Biron, C. A. and Brossay, L., NK cells and NKT cells in innate defense against viral infections. Curr. Opin. Immunol. 2001. 13: 458-464.
3. Yokoyama, W. M., Kim, S. and French, A. R., The dynamic life of natural killer cells. Annu. Rev. Immunol. 2004. 22: 405-429.
4. Sun, J. C., Ugolini, S. and Vivier, E., Immunological memory within the innate immune system. EMBO J. 2014. 33: 1295-1303.
5. Cheng, M., Chen, Y., Xiao, W., Sun, R. and Tian, Z., NK cell-based immunotherapy for malignant diseases. Cell. Mol. Immunol. 2013. 10: 230-252.
6. Fujisaki, H., Kakuda, H., Shimasaki, N., Imai, C., Ma, J., Lockey, T., Eldridge, P. et al., Expansion of highly cytotoxic human natural killer cells for cancer cell therapy. Cancer Res. 2009. 69: 4010-4017.
7. Garg, T. K., Szmania, S. M., Khan, J. A., Hoering, A., Malbrough, P. A., Moreno-Bost, A., Greenway, A. D. et al., Highly activated and expanded natural killer cells for multiple myeloma immunotherapy. Haematologica 2012. 97: 1348-1356.
8. Iliopoulou, E. G., Kountourakis, P., Karamouzis, M. V., Doufexis, D., Ardavanis, A., Baxevanis, C. N., Rigatos, G. et al., A phase I trial of adoptive transfer of allogeneic natural killer cells in patients with advanced non-small cell lung cancer. Cancer Immunol. Immunother. 2010. 59: 1781-1789.
9. Geller, M. A., Cooley, S., Judson, P. L., Ghebre, R., Carson, L. F., Argenta, P. A., Jonson, A. L. et al., A phase II study of allogeneic natural killer cell therapy to treat patients with recurrent ovarian and breast cancer. Cytotherapy 2011. 13: 98-107.
10. Rizzieri, D. A., Storms, R., Chen, D. F., Long, G., Yang, Y., Nikcevich, D. A., Gasparetto, C. et al., Natural killer cell-enriched donor lymphocyte infusions from A 3-6/6 HLA matched family member following nonmyeloablative allogeneic stem cell transplantation. Biol. Blood Marrow Transplant. 2010. 16: 1107-1114.
11. Bachanova, V. and Miller, J. S., NK cells in therapy of cancer. Crit. Rev. Oncog. 2014. 19: 133-141.
12. Staudt, L. M. and Brown, P. O., Genomic views of the immune system*. Annu. Rev. Immunol. 2000. 18: 829-859.
13. Kim, C. C. and Lanier, L. L., Beyond the transcriptome: completion of act one of the Immunological Genome Project. Curr. Opin. Immunol. 2013. 25: 593-597.
14. Germain, R. N., Meier-Schellersheim, M., Nita-Lazar, A. and Fraser, I. D., Systems biology in immunology: a computational modeling perspective. Annu. Rev. Immunol. 2011. 29: 527-585.
15. Benoist, C., Germain, R. N. and Mathis, D., A plaidoyer for 'systems immunology'. Immunol. Rev. 2006. 210: 229-234.
16. + fractions. Leukemia 2004. 18: 556-565.
17. Park, K. U., Jin, P., Sabatino, M., Feng, J., Civini, S., Khuu, H., Berg, M. et al., Gene expression analysis of ex vivo expanded and freshly isolated NK cells from cancer patients. J. Immunother. 2010. 33: 945-955.
18. Bottcher, A., Ostwald, J., Koczan, D., Knecht, R., Kramp, B. and Dommerich, S., Gene expression profiling of circulating natural killer cells in head and neck squamous cell carcinoma. Cancer Genomics Proteomics 2013. 10: 197-207.
19. Gillard-Bocquet, M., Caer, C., Cagnard, N., Crozet, L., Perez, M., Fridman, W. H., Sautes-Fridman, C. et al., Lung tumor microenvironment induces specific gene expression signature in intratumoral NK cells. Front. Immunol. 2013. 4: 19.
20. Du, X., Tang, Y., Xu, H., Lit, L., Walker, W., Ashwood, P., Gregg, J. P. et al., Genomic profiles for human peripheral blood T cells, B cells, natural killer cells, monocytes, and polymorphonuclear cells: comparisons to ischemic stroke, migraine, and Tourette syndrome. Genomics 2006. 87: 693-703.
21. Liu, B., Li, Z., Mahesh, S. P., Pantanelli, S., Hwang, F. S., Siu, W. O. and Nussenblatt, R. B., Glucocorticoid-induced tumor necrosis factor receptor negatively regulates activation of human primary natural killer (NK) cells by blocking proliferative signals and increasing NK cell apoptosis. J. Biol. Chem. 2008. 283: 8202-8210.
22. Levanon, D., Negreanu, V., Lotem, J., Bone, K. R., Brenner, O., Leshkowitz, D. and Groner, Y., Transcription factor Runx3 regulates interleukin-15-dependent natural killer cell activation. Mol. Cell. Biol. 2014. 34: 1158-1169.
23. Daussy, C., Faure, F., Mayol, K., Viel, S., Gasteiger, G., Charrier, E., Bienvenu, J. et al., T-bet and Eomes instruct the development of two distinct natural killer cell lineages in the liver and in the bone marrow. J. Exp. Med. 2014. 211: 563-577.
24. Kidd, B. A., Peters, L. A., Schadt, E. E. and Dudley, J. T., Unifying immunology with informatics and multiscale biology. Nat. Immunol. 2014. 15: 118-127.
25. Shay, T. and Kang, J., Immunological Genome Project and systems immunology. Trends Immunol. 2013. 34: 602-609.
26. Benoist, C., Lanier, L., Merad, M., Mathis, D. and Immunological Genome, P., Consortium biology in immunology: the perspective from the Immunological Genome Project. Nat. Rev. Immunol. 2012. 12: 734-740.
27. Zhang, B. and Horvath, S., A general framework for weighted gene co-expression network analysis. Stat. Appl. Genet. Mol. Biol. 2005. 4: Article17.
28. Bonneau, R., Reiss, D. J., Shannon, P., Facciotti, M., Hood, L., Baliga, N. S. and Thorsson, V., The Inferelator: an algorithm for learning parsimonious regulatory networks from systems-biology data sets de novo. Genome Biol. 2006. 7: R36.
29. Wang, F., Zhou, Y., Fu, B., Wu, Y., Zhang, R., Sun, R., Tian, Z. et al., Molecular signatures and transcriptional regulatory networks of human immature decidual NK and mature peripheral NK cells. Eur. J. Immunol. 2014. 44: 2771-2784.
30. Ashburner, M., Ball, C. A., Blake, J. A., Botstein, D., Butler, H., Cherry, J. M., Davis, A. P. et al., Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat. Genet. 2000. 25: 25-29.
31. Zuberi, K., Franz, M., Rodriguez, H., Montojo, J., Lopes, C. T., Bader, G. D. and Morris, Q., GeneMANIA prediction server 2013 update. Nucleic Acids Res. 2013. 41: W115-W122.
32. Shannon, P., Markiel, A., Ozier, O., Baliga, N. S., Wang, J. T., Ramage, D., Amin, N. et al., Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 2003. 13: 2498-2504.
33. Franceschini, A., Szklarczyk, D., Frankild, S., Kuhn, M., Simonovic, M., Roth, A., Lin, J. et al., STRING v9.1: protein-protein interaction networks, with increased coverage and integration. Nucleic Acids Res. 2013. 41: D808-D815.
34. Jiang, C., Xuan, Z., Zhao, F. and Zhang, M. Q., TRED: a transcriptional regulatory element database, new entries and other development. Nucleic Acids Res. 2007. 35: D137-D140.
35. Wang, Q., 3DScape: three dimensional visualization plug-in for Cytoscape, Available from Nature Precedings 2011.
36. Krzywinski, M., Schein, J., Birol, I., Connors, J., Gascoyne, R., Horsman, D., Jones, S. J. et al., Circos: an information aesthetic for comparative genomics. Genome Res. 2009. 19: 1639-1645.
37. Jacomy, M., Venturini, T., Heymann, S. and Bastian, M., ForceAtlas2, a continuous graph layout algorithm for handy network visualization designed for the Gephi software. PLoS One 2014. 9: e98679.
38. Fu, B., Tian, Z. and Wei, H., Subsets of human natural killer cells and their regulatory effects. Immunology 2014. 141: 483-489.
39. Haddad, R., Guardiola, P., Izac, B., Thibault, C., Radich, J., Delezoide, A. L., Baillou, C. et al., Molecular characterization of early human T/NK and B-lymphoid progenitor cells in umbilical cord blood. Blood 2004. 104: 3918-3926.
40. Hao, Q. L., Zhu, J., Price, M. A., Payne, K. J., Barsky, L. W. and Crooks, G. M., Identification of a novel, human multilymphoid progenitor in cord blood. Blood 2001. 97: 3683-3690.
41. Bezman, N. A., Kim, C. C., Sun, J. C., Min-Oo, G., Hendricks, D. W., Kamimura, Y., Best, J. A. et al., Molecular definition of the identity and activation of natural killer cells. Nat. Immunol. 2012. 13: 1000-1009.
42. Hanna, J., Bechtel, P., Zhai, Y., Youssef, F., McLachlan, K. and Mandelboim, O., Novel insights on human NK cells' immunological modalities revealed by gene expression profiling. J. Immunol. 2004. 173: 6547-6563.
43. Koopman, L. A., Kopcow, H. D., Rybalov, B., Boyson, J. E., Orange, J. S., Schatz, F., Masch, R. et al., Human decidual natural killer cells are a unique NK cell subset with immunomodulatory potential. J. Exp. Med. 2003. 198: 1201-1212.
44. Wendt, K., Wilk, E., Buyny, S., Buer, J., Schmidt, R. E. and Jacobs, R., Gene and protein characteristics reflect functional diversity of CD56dim and CD56bright NK cells. J. Leukoc. Biol. 2006. 80: 1529-1541.
45. Hanna, J., Goldman-Wohl, D., Hamani, Y., Avraham, I., Greenfield, C., Natanson-Yaron, S., Prus, D. et al., Decidual NK cells regulate key developmental processes at the human fetal-maternal interface. Nat. Med. 2006. 12: 1065-1074.
46. Fu, B., Li, X., Sun, R., Tong, X., Ling, B., Tian, Z. and Wei, H., Natural killer cells promote immune tolerance by regulating inflammatory TH17 cells at the human maternal-fetal interface. Proc. Natl. Acad. Sci. USA 2013. 110: E231-E240.
47. Moffett, A. and Loke, C., Immunology of placentation in eutherian mammals. Nat. Rev. Immunol. 2006. 6: 584-594.
48. Brosens, I., Pijnenborg, R., Vercruysse, L. and Romero, R., The "Great Obstetrical Syndromes" are associated with disorders of deep placentation. Am. J. Obstet. Gynecol. 2011. 204: 193-201.
49. Xiong, S., Sharkey, A. M., Kennedy, P. R., Gardner, L., Farrell, L. E., Chazara, O., Bauer, J. et al., Maternal uterine NK cell-activating receptor KIR2DS1 enhances placentation. J. Clin. Invest. 2013. 123: 4264-4272.
50. Gao, B., Jeong, W. I. and Tian, Z., Liver: An organ with predominant innate immunity. Hepatology 2008. 47: 729-736.
51. Sun, H., Sun, C., Tian, Z. and Xiao, W., NK cells in immunotolerant organs. Cell. Mol. Immunol. 2013. 10: 202-212.
52. Yamagiwa, S., Kamimura, H. and Ichida, T., Natural killer cell receptors and their ligands in liver diseases. Med. Mol. Morphol. 2009. 42: 1-8.
53. Peng, H., Jiang, X., Chen, Y., Sojka, D. K., Wei, H., Gao, X., Sun, R. et al., Liver-resident NK cells confer adaptive immunity in skin-contact inflammation. J. Clin. Invest. 2013. 123: 1444-1456.
54. Korn, T., Bettelli, E., Oukka, M. and Kuchroo, V. K., IL-17 and Th17 cells. Annu. Rev. Immunol. 2009. 27: 485-517.
55. + regulatory T cells controlled by the transcription factor Egr-2. Proc. Natl. Acad. Sci. USA 2009. 106: 13974-13979.
56. + T regulatory cells. J. Immunol. 2010. 184: 3433-3441.
57. Gautier, E. L., Shay, T., Miller, J., Greter, M., Jakubzick, C., Ivanov, S., Helft, J. et al., Gene-expression profiles and transcriptional regulatory pathways that underlie the identity and diversity of mouse tissue macrophages. Nat. Immunol. 2012. 13: 1118-1128.
58. Kopcow, H. D., Eriksson, M., Mselle, T. F., Damrauer, S. M., Wira, C. R., Sentman, C. L. and Strominger, J. L., Human decidual NK cells from gravid uteri and NK cells from cycling endometrium are distinct NK cell subsets. Placenta 2010. 31: 334-338.
59. Guimont-Desrochers, F., Boucher, G., Dong, Z., Dupuis, M., Veillette, A. and Lesage, S., Redefining interferon-producing killer dendritic cells as a novel intermediate in NK-cell differentiation. Blood 2012. 119: 4349-4357.
60. + NK-cell subset. Blood 2010. 116: 3865-3874.
61. Menssen, A., Edinger, G., Grun, J. R., Haase, U., Baumgrass, R., Grutzkau, A., Radbruch, A. et al., SiPaGene: a new repository for instant online retrieval, sharing and meta-analyses of GeneChip expression data. BMC Genomics 2009. 10: 98.
62. Allantaz, F., Cheng, D. T., Bergauer, T., Ravindran, P., Rossier, M. F., Ebeling, M., Badi, L. et al., Expression profiling of human immune cell subsets identifies miRNA-mRNA regulatory relationships correlated with cell type specific expression. PLoS One 2012. 7: e29979.
63. Abbas, A. R., Baldwin, D., Ma, Y., Ouyang, W., Gurney, A., Martin, F., Fong, S. et al., Immune response in silico (IRIS): immune-specific genes identified from a compendium of microarray expression data. Genes Immun. 2005. 6: 319-331.
64. Jojic, V., Shay, T., Sylvia, K., Zuk, O., Sun, X., Kang, J., Regev, A. et al., Identification of transcriptional regulators in the mouse immune system. Nat. Immunol. 2013. 14: 633-643.
65. Hidalgo, L. G., Einecke, G., Allanach, K. and Halloran, P. F., The transcriptome of human cytotoxic T cells: similarities and disparities among allostimulated CD4(+) CTL, CD8(+) CTL and NK cells. Am. J. Transplant. 2008. 8: 627-636.
66. Rajagopalan, S. and Long, E. O., Cellular senescence induced by CD158d reprograms natural killer cells to promote vascular remodeling. Proc. Natl. Acad. Sci. USA 2012. 109: 20596-20601.
67. Long, E. O., Kim, H. S., Liu, D., Peterson, M. E. and Rajagopalan, S., Controlling natural killer cell responses: integration of signals for activation and inhibition. Annu. Rev. Immunol. 2013. 31: 227-258.
68. Narni-Mancinelli, E., Ugolini, S. and Vivier, E., Tuning the threshold of natural killer cell responses. Curr. Opin. Immunol. 2013. 25: 53-58.
69. Marcais, A., Viel, S., Grau, M., Henry, T., Marvel, J. and Walzer, T., Regulation of mouse NK cell development and function by cytokines. Front. Immunol. 2013. 4: 450.
70. Apps, R., Sharkey, A., Gardner, L., Male, V., Trotter, M., Miller, N., North, R. et al., Genome-wide expression profile of first trimester villous and extravillous human trophoblast cells. Placenta 2011. 32: 33-43.
71. Stegmann, K. A., Bjorkstrom, N. K., Veber, H., Ciesek, S., Riese, P., Wiegand, J., Hadem, J. et al., Interferon-alpha-induced TRAIL on natural killer cells is associated with control of hepatitis C virus infection. Gastroenterology 2010. 138: 1885-1897.
72. Fehniger, T. A., Cai, S. F., Cao, X., Bredemeyer, A. J., Presti, R. M., French, A. R. and Ley, T. J., Acquisition of murine NK cell cytotoxicity requires the translation of a pre-existing pool of granzyme B and perforin mRNAs. Immunity 2007. 26: 798-811.
73. Dybkaer, K., Iqbal, J., Zhou, G., Geng, H., Xiao, L., Schmitz, A., d'Amore, F. et al., Genome wide transcriptional analysis of resting and IL2 activated human natural killer cells: gene expression signatures indicative of novel molecular signaling pathways. BMC Genomics 2007. 8: 230.
74. Hodge, D. L., Schill, W. B., Wang, J. M., Blanca, I., Reynolds, D. A., Ortaldo, J. R. and Young, H. A., IL-2 and IL-12 alter NK cell responsiveness to IFN-gamma-inducible protein 10 by down-regulating CXCR3 expression. J. Immunol. 2002. 168: 6090-6098.
75. Rahim, M. M., Tu, M. M., Mahmoud, A. B., Wight, A., Abou-Samra, E., Lima, P. D. and Makrigiannis, A. P., Ly49 receptors: innate and adaptive immune paradigms. Front. Immunol. 2014. 5: 145.
76. Ortaldo, J. R., Bere, E. W., Hodge, D. and Young, H. A., Activating Ly-49 NK receptors: central role in cytokine and chemokine production. J. Immunol. 2001. 166: 4994-4999.
77. Li, C., Houser, B. L., Nicotra, M. L. and Strominger, J. L., HLA-G homodimer-induced cytokine secretion through HLA-G receptors on human decidual macrophages and natural killer cells. Proc. Natl. Acad. Sci. USA 2009. 106: 5767-5772.
78. Roetynck, S., Baratin, M., Johansson, S., Lemmers, C., Vivier, E. and Ugolini, S., Natural killer cells and malaria. Immunol. Rev. 2006. 214: 251-263.
79. Kim, C. C., Parikh, S., Sun, J. C., Myrick, A., Lanier, L. L., Rosenthal, P. J. and DeRisi, J. L., Experimental malaria infection triggers early expansion of natural killer cells. Infect. Immun. 2008. 76: 5873-5882.
80. Miletic, A., Krmpotic, A. and Jonjic, S., The evolutionary arms race between NK cells and viruses: who gets the short end of the stick? Eur. J. Immunol. 2013. 43: 867-877.
81. Min-Oo, G., Bezman, N. A., Madera, S., Sun, J. C. and Lanier, L. L., Proapoptotic Bim regulates antigen-specific NK cell contraction and the generation of the memory NK cell pool after cytomegalovirus infection. J. Exp. Med. 2014. 211: 1289-1296.
82. Miller, J. S., Therapeutic applications: natural killer cells in the clinic. Hematology Am. Soc. Hematol. Educ. Program 2013. 2013: 247-253.
83. Lugli, E., Marcenaro, E. and Mavilio, D., NK cell subset redistribution during the course of viral infections. Front. Immunol. 2014. 5: 390.
84. Sun, C., Fu, B., Gao, Y., Liao, X., Sun, R., Tian, Z. and Wei, H., TGF-beta1 down-regulation of NKG2D/DAP10 and 2B4/SAP expression on human NK cells contributes to HBV persistence. PLoS Pathog. 2012. 8: e1002594.
85. Kottilil, S., Shin, K., Jackson, J. O., Reitano, K. N., O'Shea, M. A., Yang, J., Hallahan, C. W. et al., Innate immune dysfunction in HIV infection: effect of HIV envelope-NK cell interactions. J. Immunol. 2006. 176: 1107-1114.
86. Iqbal, J., Weisenburger, D. D., Chowdhury, A., Tsai, M. Y., Srivastava, G., Greiner, T. C., Kucuk, C. et al., Natural killer cell lymphoma shares strikingly similar molecular features with a group of non-hepatosplenic gammadelta T-cell lymphoma and is highly sensitive to a novel aurora kinase A inhibitor in vitro. Leukemia 2011. 25: 348-358.
87. Mavilio, D., Lombardo, G., Benjamin, J., Kim, D., Follman, D., Marcenaro, E., O'Shea, M. A. et al., Characterization of CD56-/CD16+ natural killer (NK) cells: a highly dysfunctional NK subset expanded in HIV-infected viremic individuals. Proc. Natl. Acad. Sci. USA 2005. 102: 2886-2891.
88. Mavilio, D., Benjamin, J., Daucher, M., Lombardo, G., Kottilil, S., Planta, M. A., Marcenaro, E. et al., Natural killer cells in HIV-1 infection: dichotomous effects of viremia on inhibitory and activating receptors and their functional correlates. Proc. Natl. Acad. Sci. USA 2003. 100: 15011-15016.
89. Imai, K., Matsuyama, S., Miyake, S., Suga, K. and Nakachi, K., Natural cytotoxic activity of peripheral-blood lymphocytes and cancer incidence: an 11-year follow-up study of a general population. Lancet 2000. 356: 1795-1799.
90. Jin, J., Fu, B., Mei, X., Yue, T., Sun, R., Tian, Z. and Wei, H., CD11b(-)CD27(-) NK cells are associated with the progression of lung carcinoma. PLoS One 2013. 8: e61024.
91. Vitale, M., Cantoni, C., Pietra, G., Mingari, M. C. and Moretta, L., Effect of tumor cells and tumor microenvironment on NK-cell function. Eur. J. Immunol. 2014. 44: 1582-1592.
92. Ng, S. B., Selvarajan, V., Huang, G., Zhou, J., Feldman, A. L., Law, M., Kwong, Y. L. et al., Activated oncogenic pathways and therapeutic targets in extranodal nasal-type NK/T cell lymphoma revealed by gene expression profiling. J. Pathol. 2011. 223: 496-510.